Purchase Order HHSF223201510727P

Avedro, Inc., a subsidiary of Glaukos Corporation specializing in ophthalmic medical devices and pharmaceuticals, was awarded a delivery order valued at $169,104.64 for Travoprost 75 micrograms by Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department of Veterans Affairs. The contract, awarded February 1, 2026, with an ultimate completion date of January 31, 2027, operates under a firm fixed-price structure with no set-aside designation. The place of...

This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Olopatadine HCl 0.1% eye drops in 5 ml vials, with a total ceiling value of $1,696.92 and a completion date of January 27, 2025. The contract is a firm fixed-price Delivery Order and does not have a set-aside designation, indicating open competition....

This federal contract award, with ID SPE2DB20D3505|SPE2DB23FT6B6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4559721980 - Olopatadine HCL 0.1% eye drops (5 ml). The $2,844.70 firm fixed-price delivery order has a completion date of January 26, 2023 and was awarded on January 25, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and holds an...

<p>The National Institutes of Health awarded an Other Transaction Agreement to Lacristat LLC for COSMIC (Closed-Loop Sensing and Microdosing for Dry Eye and Systemic Disease Management) on January 29, 2026, with a ceiling value of $16,356,306.90. The agreement sits outside the Federal Acquisition Regulation framework and is structured as an OTA prototype or R&amp;D effort. Performance will occur in Chicago, Illinois. The ultimate completion date is January 28, 2030.</p>

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,125.53, is for the delivery of OLOPATADINE HCL 0.1% eye drops, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of April 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Olopatadine HCl 0.1% eye drops, a prescription medication, with a ceiling value of $1,741.97 and a performance period through April 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical,...

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,093.28 contract is for the delivery of Olopatadine HCl 0.1% eye drops, a medication used to treat eye inflammation and allergy symptoms. The award is not set aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of BIMATOPROST 0.03% EYE DROPS 2.5ML. The contract, valued at $2,659.08, is a Firm Fixed Price Delivery Order with a period of performance through December 13, 2022. The contract is not designated as a set-aside and was awarded under open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...

The Food and Drug Administration awarded a $950,450 cost-plus-fixed-fee contract to CFD Research Corporation on June 12, 2023, to develop a computational fluid dynamics and physiologically-based pharmacokinetic (CFD-PBPK) framework for supporting bioequivalence evaluation of ophthalmic drugs. This contract responds to the FDA's Broad Agency Announcement seeking advanced research and development proposals to further regulatory science and innovation, specifically addressing the modernization of...

This federal contract award, valued at $1,830.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Bimatoprost 0.03% eye drops, a medication used to treat glaucoma. The contract is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at up to $999,999,999.00 and runs through November...